FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

771868004: Product containing clobetasol and neomycin and nystatin in cutaneous dose form (medicinal product form)


Status: current, Defined. Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3707630013 Product containing clobetasol and neomycin and nystatin in cutaneous dose form (medicinal product form) en Fully specified name Active Case insensitive SNOMED CT core
3707631012 Clobetasol- and neomycin- and nystatin-containing product in cutaneous dose form en Synonym Active Case insensitive SNOMED CT core


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Clobetasol- and neomycin- and nystatin-containing product in cutaneous dose form Is a Neomycin-containing product in cutaneous dose form true Inferred relationship Some
Clobetasol- and neomycin- and nystatin-containing product in cutaneous dose form Has active ingredient Nystatin true Inferred relationship Some 2
Clobetasol- and neomycin- and nystatin-containing product in cutaneous dose form Is a Clobetasol-containing product in cutaneous dose form true Inferred relationship Some
Clobetasol- and neomycin- and nystatin-containing product in cutaneous dose form Is a Nystatin-containing product in cutaneous dose form true Inferred relationship Some
Clobetasol- and neomycin- and nystatin-containing product in cutaneous dose form Has active ingredient Clobetasol true Inferred relationship Some 3
Clobetasol- and neomycin- and nystatin-containing product in cutaneous dose form Has manufactured dose form Cutaneous dose form true Inferred relationship Some
Clobetasol- and neomycin- and nystatin-containing product in cutaneous dose form Has active ingredient Neomycin true Inferred relationship Some 1
Clobetasol- and neomycin- and nystatin-containing product in cutaneous dose form Is a Clobetasol- and neomycin- and nystatin-containing product true Inferred relationship Some
Clobetasol- and neomycin- and nystatin-containing product in cutaneous dose form Plays role Antibacterial therapeutic role true Inferred relationship Some
Clobetasol- and neomycin- and nystatin-containing product in cutaneous dose form Plays role Antifungal therapeutic role true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Clobetasol and neomycin and nystatin only product in cutaneous dose form Is a True Clobetasol- and neomycin- and nystatin-containing product in cutaneous dose form Inferred relationship Some

Reference Sets

Description inactivation indicator reference set

Back to Start